Schrödinger, Inc.

SDGR

$30.47

Updated: 23/09/2026, 16:09:50

Market Cap

$2.28B

Sector

Technology

Industry

Software - Application

Country

Stock valuation chart

One-year closing share-price history for SDGR

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

USD

NASDAQ

CEO: Ramy Farid

Employees: 850

https://www.schrodinger.com

Asset Summaries

Latest generated summaries for SDGR

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for SDGR.

Share price: $30.47
Market cap: $2.28B
Exchange: NASDAQ
Currency: USD
CEO: Ramy Farid
Employees: 850
IPO date: 05/02/2020
Beta: 1.693
Last dividend: $0.00
Day range: $29.70 – $30.86
52-week range: $10.95 – $31.60
1-day performance: -0.75%
1-year performance: 178.39%
Current drawdown (1Y): -3.56%
CIK: 0001490978
CUSIP: 80810D103
ISIN: US80810D1037
Created: 07/12/2025, 14:09:40
Last update: 23/09/2026, 16:09:50

Track Schrödinger, Inc. with an AI analyst

See which prediction-market events move SDGR, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to SDGR from your Railway `news_articles` table.

Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 14/05/2026, 01:50:50

Schrödinger, Inc. (NASDAQ:SDGR): Analyzing Recent Financial Performance and Biotech Innovation

Market Data • Market Data • 06/05/2026, 06:06:19

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 05/05/2026, 22:21:14

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

Business Wire • STOCK • 21/04/2026, 10:30:00

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Business Wire • STOCK • 17/04/2026, 10:30:00

Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of “Hold” by Brokerages

Defense World • STOCK • 28/03/2026, 04:00:46

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Seeking Alpha • STOCK • 23/03/2026, 06:02:21

Schrödinger, Inc. (SDGR) Q4 2025 Earnings Call Transcript

Seeking Alpha • STOCK • 25/02/2026, 21:17:49